SCHOTT Tubing India to boost capacity at Gujarat facility

Germany-based pharma glass and packaging firm, SCHOTT, has announced the launch of a new glass tank at its manufacturing plant in Jambusar, Gujarat. The company – which is celebrating 20 years of operations in India – is further growing its production capacity through this new tank facility with a total investment of more than Euro 20-mn (approximately Rs. 180-crore).
Construction work on the new tank facility has already begun and is expected to be completed within 18 months. Production from the new tank is scheduled to begin by January 2020. Mr. Georg Sparschuh, Managing Director, SCHOTT Glass India Pvt. Ltd. said that the new facility will help increase the company’s production capacity by an additional 50%.
Schott said the facility will help fulfil the constantly growing demand of its premium borosilicate glass tubing like Fiolax clear. It is used for high quality pharmaceutical packaging, especially vials and ampoules for India as well as for export markets.
“The rapid development of the Indian pharmaceutical market requires a strong growth of high-end pharmaceutical packaging and in consequence high-end pharmaceutical tubing. We estimate a market growth for premium packaging and therefore for tubing to continue on a very strong level in the coming years. In addition to the supply of the domestic market, Schott Tubing India will also serve the strong growing Asian market outside of India and will therefore be an important hub for the Asian market,” commented Dr. Patrick Markschlaeger, Executive Vice President, SCHOTT AG, Business Unit Tubing.
SCHOTT’s India plant functions as a production hub for SCHOTT pharmaceutical tubing in Asia and produces the branded Fiolax pharmaceutical tubing.
Looking for chemical products? Let suppliers reach out to you!
2026-06-16
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
Eli Lilly to Appeal UK Rejection of Alzheimer's Drug Kisunla Impacting Thousands of Patients
-
Abbott to Market MSD’s Sitagliptin Brands in India Targeting 20 Percent of Diabetes Market
-
48 Scientists Rally as CRO Giant Faces 1.8 Billion RMB Dispute and Criminal Allegations
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
Recommend Reading
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
FDA Clears Sanofi’s Wayrilz (rilzabrutinib) for Adult ITP; U.S. Launch in September
-
Aficamten Beats Metoprolol in Obstructive HCM, Strengthening Case Ahead of FDA Decision
-
AstraZeneca Targets Year-End Filing for Novel Hypertension Drug Baxdrostat
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
In April, China's titanium dioxide market price increased by 23.6%
-
Ammonium Sulfate Tends to Stabilize After Continuing Its Decline (June 1–June 5)
-
In April, the Chinese urea market maintained a strong performance
-
Ethylene Oxide Prices Drop Sharply in Early June
-
In April, the natural rubber market in China showed a slight increase